Prospective Study of Pravastatin in the Elderly at Risk "PROSPER"

Completed

Phase 3 Results

Summary of Purpose

To investigate the prophylactic efficacy of pravastatin against major vascular events in elderly patients with preexisting vascular disease or significant vascular risk.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 December 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Bristol-Meyers Squibb, USA

Trial Design

Randomized, multicenter, double-blind, placebo-controlled trial.

Contacts

Not available